You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Neurokinin B is a Preferred Agonist for a Neuronal Substance P Receptor and Its Action is Antagonized by Enkephalin
Ralph Laufer, Uri Wormser, Zeev Y. Friedman, Chaim Gilon, Michael Chorev and Zvi Selinger
Proceedings of the National Academy of Sciences of the United States of America
Vol. 82, No. 21 (Nov. 1, 1985), pp. 7444-7448
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/26387
Page Count: 5
You can always find the topics here!Topics: Receptors, Ileum, Esters, Agonists, Tachykinins, Dose response relationship, Dosage, Atropine, Inurement, Tetrodotoxin
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Receptor specificity of the substance P-related peptides neurokinin A and neurokinin B was studied in the isolated guinea pig ileum. Substance P and the recently discovered neurokinins elicit contraction of the ileum both directly through action on a muscle cell receptor and indirectly through stimulation of a neuronal receptor, leading to release of acetylcholine, which causes muscle contraction via muscarinic receptors. Two specific assay procedures for the function of the neuronal receptor were developed. The muscular receptor was inactivated either by desensitization with the selective agonist substance P methyl ester or by receptor blockade with the selective antagonist [Arg6, D-Trp7,9, Me-Phe8]substance P-(6-11) hexapeptide. Both procedures revealed that the neuronal receptor is clearly distinct from the muscular receptor, since it exhibits different agonist specificity and is insensitive to antagonists of the muscular receptor. Neurokinin B was found to be the most potent agonist (EC50 = 1 nM) for the neuronal receptor. Furthermore, [D-Ala2, Met5]enkephalinamide inhibited in a naloxone-sensitive manner the effect of neurokinin B mediated via the neuronal receptor. These results suggest that the different mammalian tachykinins can play specific physiological roles by virtue of their distinct receptor specificities.
Proceedings of the National Academy of Sciences of the United States of America © 1985 National Academy of Sciences